ライフサイエンスコーパス: diagnostic imaging

1 atment of antibody-mediated autoimmunity and diagnostic imaging.

2 risk for significant radiation exposure from diagnostic imaging.

3 CA IX a valuable target for preclinical and diagnostic imaging.

4 hen conducting modeling-based assessments of diagnostic imaging.

5 d laboratory findings can guide selection of diagnostic imaging.

6 ctral mammography and targeted US as part of diagnostic imaging.

7 siderations that can help achieve successful diagnostic imaging.

8 ential cancer from radiation exposure due to diagnostic imaging.

9 ltrating leukocytes as biomarker sources for diagnostic imaging.

10 stem cell therapy in addition to enhanced MR diagnostic imaging.

11 ics describes the combination of therapy and diagnostic imaging.

12 e an elusive concept: the appropriateness of diagnostic imaging.

13 deoxyglucose positron emission tomography in diagnostic imaging.

14 tant tool with which to analyze the value of diagnostic imaging.

15 the need for a more conservative approach to diagnostic imaging.

16 es, thereby requiring definitive noninvasive diagnostic imaging.

17 d stunning can occur with 185 MBq of 131I in diagnostic imaging.

18 nical centers of excellence, and advances in diagnostic imaging.

19 outlines aspects of technology assessment of diagnostic imaging.

20 ilent and undetected by aminotransferases or diagnostic imaging.

21 epair of TOF/PA without further preoperative diagnostic imaging.

22 g radiolabeled folate-chelate conjugates for diagnostic imaging.

23 to rely heavily on the clinical gestalt and diagnostic imaging.

24 otential utility in therapeutic delivery and diagnostic imaging.

25 ograms that had proved negative or benign at diagnostic imaging.

26 =.027) in the group recalled for subsequent diagnostic imaging.

27 profile would make the antibody suitable for diagnostic imaging.

28 tigen target for prostate cancer therapy and diagnostic imaging.

29 f normal structures after recall for further diagnostic imaging.

30 nd enforcing their own quality standards for diagnostic imaging.

31 c and functional imaging, has revolutionized diagnostic imaging.

32 and In(III) radionuclides are widely used in diagnostic imaging.

33 ustic sensing, energy deposition and medical diagnostic imaging.

34 ial diagnosis of soft-tissue masses found in diagnostic imaging.

35 lating apoptosis and are extensively used in diagnostic imaging.

36 idated target for therapeutic approaches and diagnostic imaging.

37 nd image quality beyond what is required for diagnostic imaging.

38 appendicitis, and roughly halves the need of diagnostic imaging.

39 reed to undergo genotyping, examination, and diagnostic imaging.

40 gastrointestinal segment were documented on diagnostic imaging.

41 could reduce the need of potentially harmful diagnostic imaging.

42 the present value of our efforts to improve diagnostic imaging?

43 There were also significant changes in major diagnostic imaging (30.5%), consultation (13.6%), and em

44 Because of pitfalls in routine diagnostic imaging, a high level of clinical suspicion m

45 Of the 13 255 (13%) who underwent diagnostic imaging, additional mammographic views were o

46 Diagnostic imaging advances are improving the ability of

47 member of the HER family (HER2), to design a diagnostic imaging agent, ((111)In-DTPA)(n)-trastuzumab-

48 h 18F will be an excellent receptor-mediated diagnostic imaging agent.

49 or (FR) type alpha is a promising target for diagnostic imaging agents and therapeutic intervention i

50 luation of the analogous Tc-99m complexes as diagnostic imaging agents for breast tumors.

51 ing candidates for continuing development as diagnostic imaging agents targeting GPER expression in c

52 scussion on the best approaches to allow new diagnostic imaging agents to become part of the health-c

53 mplexes of copper and technetium designed as diagnostic imaging agents to detect amyloid burden in th

54 Radiological diagnostic imaging allows for visualization of punctate

55 In recent years, improved diagnostic imaging and an increase in reported experienc

56 was a large increase in the rate of advanced diagnostic imaging and associated radiation exposure bet

57 als will make excellent agents for effective diagnostic imaging and drug delivery, improving patient

58 luated for transplantation undergo extensive diagnostic imaging and have increased baseline cancer ri

59 Advances in diagnostic imaging and image-guided biopsy techniques ho

60 developing and conducting clinical trials of diagnostic imaging and image-guided treatment technologi

61 nducted of the patients' medical records and diagnostic imaging and interventional procedure findings

62 ed tomography performed at the Department of Diagnostic Imaging and Interventional Radiology of the P

63 The value of diagnostic imaging and laboratory tests in differential

64 contrast agents for magnetic resonance (MR) diagnostic imaging and MR-guided interventions, includin

65 rtality, despite significant improvements in diagnostic imaging and operative mortality rates.

66 re developed incorporating both contemporary diagnostic imaging and pathology techniques, including n

67 tion of research accomplishments to clinical diagnostic imaging and patient care, and an insufficient

68 Through diagnostic imaging and peptide receptor radionuclide the

69 in breast cancer, technology developments in diagnostic imaging and radiation therapy have elucidated

70 These advances have improved diagnostic imaging and radiation therapy while expanding

71 nce, this receptor is a promising target for diagnostic imaging and radioligand therapy.

72 Radiopeptides are powerful tools for diagnostic imaging and radionuclide therapy of various d

73 s clinical potential for application in both diagnostic imaging and radionuclide therapy.

74 led liposomes have potential applications in diagnostic imaging and radionuclide therapy.

75 receptor-1 (NTR1) is a promising target for diagnostic imaging and targeted radionuclide therapy.

76 euticals containing copper radionuclides for diagnostic imaging and targeted radiotherapy has grown c

77 er radionuclides to biological molecules for diagnostic imaging and targeted radiotherapy.

78 er radionuclides to biological molecules for diagnostic imaging and targeted radiotherapy.

79 Clinicians should perform diagnostic imaging and testing for patients with low bac

80 that this multistep, pretargeting system has diagnostic imaging and therapeutic potential.

81 have great potential as selective agents for diagnostic imaging and therapeutic targeting of human ca

82 udy suggests applications for UNO peptide in diagnostic imaging and therapeutic targeting of MEMs in

83 B-FN could therefore provide a target for diagnostic imaging and therapy of cancer.

84 coustic imaging) and theranostic (concurrent diagnostic imaging and therapy) applications, especially

85 tomography and magnetic resonance imaging in diagnostic imaging and three-dimensional treatment plann

86 elivering radiopharmaceuticals to tumors for diagnostic imaging and/or radiation therapy.

87 suspected to be a sarcoma who underwent full diagnostics imaging and open bipsy with histopatological

88 y and will have profound impact on molecular diagnostics, imaging and therapeutics.

89 Clinical assessment, diagnostic imaging, and cardiorespiratory testing of pat

90 inly with medical applications of radiation, diagnostic imaging, and clinical measurement.

91 ndpoint of the presenting clinical symptoms, diagnostic imaging, and determination of plasma-phase ri

92 isciplinary approach of clinical assessment, diagnostic imaging, and laboratory assessment is necessa

93 to high-quality subspecialists, high-quality diagnostic imaging, and nonemergency admission to the ho

94 graphic characteristics, laboratory testing, diagnostic imaging, and rotavirus infection.

95 g for 2 years, including clinical pathology, diagnostic imaging, and special procedures; number of vi

96 moderate ($286) in women who also underwent diagnostic imaging, and substantially greater in women w

97 or confirmed by central review of pathology, diagnostic imaging, and surgical reports.

98 ical tests, optimizing cost-effectiveness of diagnostic imaging, and testing the risk for tumor recur

99 rea and the logistics of laboratory testing, diagnostic imaging, and the removal of waste must be con

100 antibody discovery, to aid in GSC isolation, diagnostic imaging, and therapeutic targeting.

101 ent care, especially mental health services, diagnostic imaging, and visits with moderate or high com

102 in multiple mAb-based technologies including diagnostics, imaging, and therapeutic delivery.

103 ctional materials applicable to brain cancer diagnostics, imaging, and therapy, with an emphasis on t

104 ral areas of cancer care, including in vitro diagnostics, imaging, and therapy.

105 n biomarker of EWS-FLI1 activity and a novel diagnostic imaging approach for Ewing sarcoma.

106 This methodology represents a promising diagnostic imaging approach for the early detection of c

107 nderscores the need for novel biomarkers and diagnostic imaging approaches to identify patients who m

108 ally, the TA hierarchy for the evaluation of diagnostic imaging are described.

109 population genetic studies, and contemporary diagnostic imaging, as well as a greater index of suspic

110 oup, patients received basic examination and diagnostic imaging at a stand-alone teleophthalmologic s

111 p, patients received clinical assessment and diagnostic imaging at a tertiary hospital-based retina c

112 ve a profound impact in medicine by enabling diagnostic imaging at the cellular level over large surf

113 mages from the archives of the Department of Diagnostic Imaging at the Institute of Mother and Child.

114 facility of the Department of Radiology and Diagnostic Imaging at the St.

115 al case adjudication was based on conclusive diagnostic imaging, autopsy, surgery, or 14-day follow-u

116 opancreatography rather than risk-stratified diagnostic imaging because of improved detection of chol

117 a reflection of new advances in the area of diagnostic imaging, better pharmacologic agents, and a h

118 present the differential diagnosis based on diagnostics imaging between MO and malignant tumors, suc

119 Advances in diagnostic imaging, biomarkers, and genetic testing toda

120 Most patients (86.7%) received screening and diagnostic imaging, biopsy, and surgery between multiple

121 Colorectal cancer screening with diagnostic imaging can detect polyps.

122 Emphasis is on advances in diagnostic imaging capabilities and on recent literature

123 The three-dimensional, micrometer-scale, diagnostic imaging capabilities of OCT permit rapid feed

124 agents that once photo-activated can provide diagnostic imaging capability, and elicit therapeutic ef

125 There are less data on the clinical and diagnostic imaging characteristics, management, and outc

126 ble justification were: inadequate method of diagnostic imaging chosen as a first-line tool and lacki

127 To date, most diagnostic imaging comparisons between amyloid labelling

128 son per year, of which 35% were for advanced diagnostic imaging (computed tomography [CT], magnetic r

129 ed for interhospital variation in the use of diagnostic imaging (computed tomography or ultrasonograp

130 y there appear to be four major clinical and diagnostic imaging considerations.

131 MR imaging, and other imaging technologies, diagnostic imaging costs increased at approximately same

132 ltiple sclerosis (MS), but the international diagnostic imaging criteria for MS are not necessarily h

133 The clinical and diagnostic imaging data of infants with TOF/PA treated b

134 to represent a broad range of skill sets in diagnostic imaging, different practice types (private an

135 ere divided into (a) those who had undergone diagnostic imaging during the same appointment as their

136 All diagnostic imaging examinations (n = 5 948 342) interpre

137 uture cancer rates, and exposures typical of diagnostic imaging examinations are in the range that ep

138 tal to the appropriate evaluation and use of diagnostic imaging examinations.

139 DP), and the growth rate of costs related to diagnostic imaging exceeds those of overall health care

140 Many diagnostic imaging experiments are characterized by the

141 applications were mailed to more than 1,800 diagnostic imaging facilities and more than 6,000 profes

142 resection of cancer by extending whole-body diagnostic imaging findings into the surgical suite.

143 This article presents clinical data and diagnostic imaging findings of two newborn babies with c

144 The initial diagnostic imaging findings were concordant with the bio

145 mography might increase the accessibility of diagnostic imaging for Alzheimer's disease.

146 be a useful clinical tool for comprehensive diagnostic imaging for epithelial disease and for evalua

147 ical measures are described that are used in diagnostic imaging for expressing observer agreement in

148 Thus, the volume and cost of diagnostic imaging for persistent low back pain have inc

149 The national cost of diagnostic imaging for persistent low back pain in 1990

150 The additional national cost of diagnostic imaging for persistent low back pain in 1990

151 Six (4%) cases involved additional diagnostic imaging for reevaluation; in four of these si

152 Diagnostic imaging from a cohort of 26 paediatric patien

153 n (P < .001) in mean rates of all subsequent diagnostic imaging, from 3.30 to 2.74 examinations per p

154 lective delivery of agents for drug therapy, diagnostic imaging, genetic control, or cell regulation.

155 tored for communication and documentation of diagnostic imaging, harnessing their potential requires

156 Diagnostic imaging has an ever-increasing role in the pr

157 Use of diagnostic imaging has increased significantly within fe

158 r ocular surgery, clinical presentation, and diagnostic imaging in each eye.

159 The value of early diagnostic imaging in older adults for back pain without

160 Finally, new insights in diagnostic imaging, including the evolving role of 201Tl

161 Use of advanced diagnostic imaging increased from 1996 to 2010; CT exami

162 dings in pregnant women in the Department of Diagnostic Imaging, Institute of Mother and Child, Warsa

163 hich involves the combination of therapy and diagnostic imaging into a single system, may fulfill the

164 Diagnostic imaging is also helpful in evaluating ongoing

165 At present, tumor diagnostic imaging is commonly based on hematoxylin and

166 Advanced diagnostic imaging is commonly used in the evaluation of

167 The optimal algorithm for diagnostic imaging is controversial.

168 While diagnostic imaging is frequently useful, it may not be e

169 Diagnostic imaging is indicated for patients with low ba

170 Proper diagnostic imaging is necessary.

171 The mainstay of diagnostic imaging is non-enhanced chest-computed-tomogr

172 lecular imaging has had a dramatic impact on diagnostic imaging, it has only recently begun to be int

173 In contradistinction to "classical" diagnostic imaging, it sets forth to probe the molecular

174 After further diagnostic imaging, it was recommended that biopsy or as

175 Unnecessary diagnostic imaging leads to higher costs, longer emergen

176 regression models by using examples from the diagnostic imaging literature.

177 many advances in genetics, pathophysiology, diagnostic imaging, medical treatment, medical preventio

178 itates search for the cause with the help of diagnostic imaging methods among other things.

179 t of cancer through the development of novel diagnostic imaging methods and targeted therapies.

180 Significant advances have been made in diagnostic imaging modalities for identifying malignancy

181 still considerable debate about the optimal diagnostic imaging modality for acute pulmonary embolism

182 To identify the most accurate diagnostic imaging modality for classifying pediatric ey

183 e led to more widespread utilization of this diagnostic imaging modality in the diagnosis of coronary

184 rederiksen indicated that CT scanning is the diagnostic imaging modality of choice prior to implant p

185 reformatted computed tomography (CT) is the diagnostic imaging modality of choice prior to implant p

186 Previously, the sole diagnostic imaging modality was fMRI.

187 As a diagnostic imaging modality, magnetic resonance imaging

188 Diagnostic imaging, most often magnetic resonance imagin

189 Angiography, the "gold standard" for diagnostic imaging, now seems to be in question since th

190 been capitalized upon for the prognostic and diagnostic imaging of a wide range of cancers using radi

191 nters have relatively little experience with diagnostic imaging of cardiac tumors in children, becaus

192 ge during the course of treatment, companion diagnostic imaging of CD30 could be a valuable tool in o

193 Finally, recent advances in diagnostic imaging of glymphatic function may hold the k

194 results demonstrate that high-resolution 3D diagnostic imaging of human breast cancers can, in princ

195 Modern possibilities of diagnostic imaging of infraglottic space include compute

196 ubstituents as small-molecule probes for the diagnostic imaging of metastatic melanoma has shown that

197 ately radiolabeled, are potential agents for diagnostic imaging of PR-positive breast tumors using po

198 icroscopy (VR-SIM) for rapid high-resolution diagnostic imaging of prostate biopsies in realistic poi

199 gma receptor binding ligands in non-invasive diagnostic imaging of prostate cancer and its treatment.

200 ve greatly improved preservation and enabled diagnostic imaging of the organ of Corti, even 30 hours

201 form the basis for real-time, intraoperative diagnostic imaging of tumor and metastases by minimally

202 nce may contribute to the improvement of the diagnostic imaging of tumors overexpressing GRPr.

203 examined at the Department of Radiology and Diagnostic Imaging of University Hospital No.

204 o determine those patients likely to undergo diagnostic imaging on the basis of screening mammographi

205 vascular disease has evolved into a feasible diagnostic imaging option.

206 single photon tomography may improve current diagnostic imaging paradigms and allow for enhanced risk

207 ars promise to result in dramatic changes in diagnostic imaging, particularly with respect to detecti

208 combined with cystoscopy is emerging as the diagnostic imaging pathway of choice for investigating h

209 Diagnostic imaging (plain films, computed tomography [CT

210 Whereas diagnostic imaging prioritizes the highest-quality imagi

211 These include the diagnostic imaging procedure (DIP) itself, the subject (

212 Studies returned by the query that were not diagnostic imaging procedure performance evaluations wer

213 ve questionnaire data on history of personal diagnostic imaging procedures collected prior to cancer

214 sleep and that posture must be considered in diagnostic imaging procedures developed in the future to

215 as a gold standard in the assessment of new diagnostic imaging procedures for DVT.

216 thereby alleviate the main concern in X-ray diagnostic imaging procedures today.

217 Diagnostic imaging procedures were selected on the basis

218 Diagnostic imaging provides important information for st

219 arily the same as those designed to optimize diagnostic imaging quality.

220 These new paradigms link diagnostic imaging, radiation therapy, and nuclear medic

221 vel VTE event rates were compared across VTE diagnostic imaging rate quartiles and with a quantile re

222 MAIN OUTCOME MEASURE: Advanced diagnostic imaging rates and cumulative annual radiation

223 Mean VTE diagnostic imaging rates ranged from 32 studies per 1000

224 e regression analysis and its application in diagnostic imaging research.

225 erse events, clinical laboratory values, and diagnostic imaging results were evaluated in 44 patients

226 Diagnostic imaging revealed extensive liver, pulmonary a

227 Diagnostic imaging reveals a suspicious mass, and core b

228 mfVEPs were obtained by using VERIS (Electro-Diagnostic Imaging, San Mateo, CA) with a four-electrode

229 atric acute abdominal pain and thereby guide diagnostic imaging selection.

230 n Medicare beneficiaries, 124 million unique diagnostic imaging services (totaling $5.6 billion) were

231 the past 2 decades, significant advances in diagnostic imaging, staging, surgical technique, and per

232 For those children at higher risk of CSI, diagnostic imaging strategies are evolving, with compute

233 iscuss current state-of-the-art non-invasive diagnostic imaging strategies for luminal stenosis and d

234 nd private payers have highlighted growth in diagnostic imaging studies and begun to develop approach

235 rvations and dependency within a subject for diagnostic imaging studies are discussed.

236 Advanced diagnostic imaging studies can play an important role in

237 Although avoiding sedation for diagnostic imaging studies is optimal, there are multipl

238 arding pathogenetics and new applications of diagnostic imaging studies such as positron emission tom

239 Difficulty and delay in obtaining diagnostic imaging studies to rule out deep venous throm

240 Diagnostic imaging studies, operative and pathology repo

241 correct diagnosis and allow planning further diagnostic imaging studies.

242 als has been an important, clinically useful diagnostic imaging study for almost 4 decades.

243 Historically, CT has been the diagnostic imaging study of choice; however, there is a

244 argeting of CEA-expressing tumors for either diagnostic imaging, such as with immunoSPECT and immunoP

245 Real-time virtual sonography (RVS) is a diagnostic imaging support system that can synchronize w

246 Advances in molecular oncology, diagnostic imaging, surgical approaches and long-term fo

247 Plastic surgery may affect diagnostic imaging, surgical options, and radiotherapy m

248 disease that has benefitted from advances in diagnostic imaging, surgical techniques, radiation thera

249 ologists contribute substantial value to the diagnostic imaging system.

250 lammation has allowed for the development of diagnostic imaging systems able to monitor transplanted

251 archical scheme for modeling the efficacy of diagnostic imaging systems.

252 Further, companion diagnostic imaging techniques are becoming progressively

253 Existing diagnostic imaging techniques provide limited evaluation

254 Therefore, other diagnostic imaging techniques such as FDG PET, MEG, DTI

255 ble emission properties that can be used for diagnostic imaging techniques, such as single photon emi

256 ighty-six studies were performed to evaluate diagnostic imaging technologies, and 25 were performed t

257 ssion models are needed in the evaluation of diagnostic imaging technologies.

258 st pain patients (288; 84.4%) underwent >/=1 diagnostic imaging test, most commonly coronary angiogra

259 , magnetic resonance imaging (n = 11), other diagnostic imaging tests (n = 19), nonsurgical invasive

260 inostat may modulate the results of clinical diagnostic imaging tests that depend of functional GLUT1

261 PET is a unique form of diagnostic imaging that observes in vivo biologic change

262 cal examination and unremarkable findings on diagnostic imaging, the diagnosis of CRPS was made.

263 cular AMD screening, the average referral-to-diagnostic imaging time was 22.5 days for the teleophtha

264 prehensive treatment strategy that comprises diagnostic imaging to identify sites of disease, followe

265 The average diagnostic imaging to treatment time was 16.4 days for t

266 Ultrasonography is a fundamental diagnostic imaging tool in everyday clinical practice.

267 central vestibular structures may provide a diagnostic imaging tool in these patients and a quantita

268 Using a recently developed nondestructive diagnostic imaging tool, high-resolution x-ray computed

269 cal capabilities for a variety of radiologic diagnostic imaging tools for evaluating the colon and re

270 Was it possible to use the same diagnostic imaging tools that had revolutionized the pra

271 cedures bridges the gap between the world of diagnostic imaging (typically three-dimensional imaging

272 ommendation for further evaluation including diagnostic imaging, ultrasound, clinical examination, or

273 Data on diagnostic imaging use in 2,374 adult patients with pers

274 es or to other same-specialty physicians for diagnostic imaging used imaging between 1.12 and 2.29 ti

275 Diagnostic imaging was frequently negative and initial c

276 the capitation plan, nonemergent outpatient diagnostic imaging was performed at a newly constructed

277 Diagnostic imaging was performed in potential lesions in

278 Diagnostic imaging was performed, including MRI and CT a

279 Diagnostic imaging was performed.

280 Diagnostic imaging was the fastest growing component of

281 nd to enhance the importance of differential diagnostic imaging when difficulties occur.

282 Optimizing the nature and sequence of diagnostic imaging when managing lower gastrointestinal

283 Group 1 had diagnostic imaging with 14.8 MBq of (123)I followed by t

284 lar thyroid carcinoma may be performed using diagnostic imaging with either (123)I or (131)I.